Date Filed | Type | Description |
06/08/2023 |
4
| Muralidhar Bali (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
05/26/2023 |
4
| Muralidhar Bali (Director) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns:
| Granted 30,000 options to buy
@ $2.26, valued at
$67.8k
|
|
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2022 |
4
| Muralidhar Bali (Director) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns:
| Granted 22,500 options to buy
@ $1.32, valued at
$29.7k
|
|
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/15/2021 |
4
| Muralidhar Bali (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.
Txns:
| Bought 111,736 shares
@ $8.5, valued at
$949.8k
|
|
06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/21/2021 |
4
| Muralidhar Bali (Director) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $15.24, valued at
$152.4k
|
|
04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/16/2020 |
4
| Muralidhar Bali (Director) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns:
| Converted 1,592,518 shares
@ $0 Bought 200,000 shares
@ $15, valued at
$3M
Converted 10,416,666 preferred shares
@ $0 |
|
10/08/2020 |
3
| Muralidhar Bali (Director) has filed a Form 3 on SPRUCE BIOSCIENCES, INC. |
06/09/2020 |
4
| Muralidhar Bali (Director) has filed a Form 4 on EXICURE, INC.
Txns:
| Granted 21,693 options to buy
@ $2.79, valued at
$60.5k
|
|
12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |